{
  "document": {
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the internet.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Locate control system networks and remote devices behind firewalls and isolating them from business networks.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs). Recognize VPNs may have vulnerabilities, should be updated to the most recent version available, and are only as secure as the connected devices.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also recommends users take the following measures to protect themselves from social engineering attacks: Do not click web links or open attachments in unsolicited email messages. Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams. Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "central@cisa.dhs.gov",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-16-306-01 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2016/icsma-16-306-01.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-16-306-01 - Web Version",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-16-306-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/resources-tools/resources/ics-recommended-practices"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/topics/industrial-control-systems"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/sites/default/files/publications/Cybersecurity_Best_Practices_for_Industrial_Control_Systems.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/sites/default/files/publications/emailscams0905.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ncas/tips/ST04-014"
      }
    ],
    "title": "Smiths Medical CADD-Solis Medication Safety Software Vulnerabilities",
    "tracking": {
      "current_release_date": "2025-06-05T21:56:42.285844Z",
      "generator": {
        "date": "2025-06-05T21:56:42.285725Z",
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-16-306-01",
      "initial_release_date": "2016-08-05T06:00:00.000000Z",
      "revision_history": [
        {
          "date": "2016-08-05T06:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "Initial Publication"
        },
        {
          "date": "2025-06-05T21:56:42.285844Z",
          "legacy_version": "CSAF Conversion",
          "number": "2",
          "summary": "Advisory converted into a CSAF"
        }
      ],
      "status": "final",
      "version": "2"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version",
                "name": "1.0",
                "product": {
                  "name": "Smiths Medical CADD-Solis Medication Safety Software: 1.0",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "CADD-Solis Medication Safety Software"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "2.0",
                "product": {
                  "name": "Smiths Medical CADD-Solis Medication Safety Software: 2.0",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "CADD-Solis Medication Safety Software"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "3.0",
                "product": {
                  "name": "Smiths Medical CADD-Solis Medication Safety Software: 3.0",
                  "product_id": "CSAFPID-0003"
                }
              }
            ],
            "category": "product_name",
            "name": "CADD-Solis Medication Safety Software"
          },
          {
            "branches": [
              {
                "category": "product_version",
                "name": "3.1",
                "product": {
                  "name": "Smiths Medical CADD-Solis Medication Safety Software: 3.1",
                  "product_id": "CSAFPID-0004"
                }
              }
            ],
            "category": "product_name",
            "name": "CADD-Solis Medication Safety Software"
          }
        ],
        "category": "vendor",
        "name": "Smiths Medical"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2016-8358",
      "cwe": {
        "id": "CWE-300",
        "name": "Channel Accessible by Non-Endpoint"
      },
      "notes": [
        {
          "category": "summary",
          "text": "An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003",
          "CSAFPID-0004"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Smiths Medical has released new versions of the CADD-Solis Medication Safety Software, which mitigates the identified vulnerabilities. The new versions of Smiths Medical\u2019s CADD-Solis Medication Safety Software are Version 3.2, which is distributed within the continental US, and Version 4.1, which is released outside the continental US.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ]
        },
        {
          "category": "mitigation",
          "details": "Smiths Medical recommends that CADD-Solis Medication Safety Software users install the applicable new version. In addition, Smiths Medical also recommends that users take the following additional security measures:  Apply strict password standards across systems to include, requiring the use of upper case, lower case, special characters, and a minimum password length of 8 characters. Establish and effectively manage an Active directory. Create an SQL Express database account with managed permissions for use with the CADD-Solis Medication Safety Software. Establish and assign managed Services Accounts for all servers and medical infusion pumps. Use Virtual Local Area Network (VLAN) tagging.  Implement server hardening procedures for both SQL and Windows servers.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the identified vulnerabilities or to obtain the new version of the CADD-Solis Medication Safety Software, contact Smiths Medical Technical Support at:  Telephone: +1 (800) 258 5361 or +01 614 210 7300,  Email: (mailto:info.asd@smiths-medical.com).",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ],
          "url": "mailto:info.asd@smiths-medical.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 8.5,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2016-8355",
      "cwe": {
        "id": "CWE-732",
        "name": "Incorrect Permission Assignment for Critical Resource"
      },
      "notes": [
        {
          "category": "summary",
          "text": "An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003",
          "CSAFPID-0004"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Smiths Medical has released new versions of the CADD-Solis Medication Safety Software, which mitigates the identified vulnerabilities. The new versions of Smiths Medical\u2019s CADD-Solis Medication Safety Software are Version 3.2, which is distributed within the continental US, and Version 4.1, which is released outside the continental US.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ]
        },
        {
          "category": "mitigation",
          "details": "Smiths Medical recommends that CADD-Solis Medication Safety Software users install the applicable new version. In addition, Smiths Medical also recommends that users take the following additional security measures:  Apply strict password standards across systems to include, requiring the use of upper case, lower case, special characters, and a minimum password length of 8 characters. Establish and effectively manage an Active directory. Create an SQL Express database account with managed permissions for use with the CADD-Solis Medication Safety Software. Establish and assign managed Services Accounts for all servers and medical infusion pumps. Use Virtual Local Area Network (VLAN) tagging.  Implement server hardening procedures for both SQL and Windows servers.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the identified vulnerabilities or to obtain the new version of the CADD-Solis Medication Safety Software, contact Smiths Medical Technical Support at:  Telephone: +1 (800) 258 5361 or +01 614 210 7300,  Email: (mailto:info.asd@smiths-medical.com).",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ],
          "url": "mailto:info.asd@smiths-medical.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 9.9,
            "baseSeverity": "CRITICAL",
            "vectorString": "CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H",
            "version": "3.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003",
            "CSAFPID-0004"
          ]
        }
      ]
    }
  ]
}